Register for our S/EIS Fund

‘Stemnovate’- which is advancing ‘organ on chip’ technology-has closed its seed investment round with a team of 8 angels led by o2h ventures, whose co-founder Sunil Shah is joining the board as chairman.The innovative company says the backing of the strong team of experienced Cambridge and London angels will strengthen its research and business development strategy using Bioengineering techniques for the advancement of pre-clinical drug testing.